Melatonin therapy in shift workers with difficulty falling asleep: A randomized, double-blind, placebo-controlled...

Area of Science:

• Sleep Medicine
• Chronobiology
• Pharmacology

Background:

• Shift work commonly leads to disturbed sleep patterns.
• Exogenous melatonin is hypothesized to reduce sleep latency and enhance sleep quality.
• Investigating melatonin's efficacy for shift workers with sleep onset difficulties is crucial.

Purpose of the Study:

• To assess the effectiveness of 3mg melatonin, administered 30 minutes before sleep.
• To evaluate melatonin's impact on shift workers experiencing difficulty falling asleep.
• To determine if melatonin can improve key sleep parameters in this population.

Main Methods:

• Utilized Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI) for participant selection.
• Conducted a randomized, double-blind, placebo-controlled crossover study.
• Analyzed sleep parameters including Total Sleep Time (TST), Sleep Onset Latency (SOL), Sleep Efficiency (SE), and Wake After Sleep Onset (WASO) using somnowatch.

Main Results:

• Melatonin treatment significantly increased Sleep Efficiency (SE) from 82.1% to 85.5%.
• Melatonin significantly decreased Sleep Onset Latency (SOL) from 0.27h to 0.20h compared to baseline and placebo.
• No significant effects of melatonin were observed on Total Sleep Time (TST) or Wake After Sleep Onset (WASO).

Conclusions:

• Melatonin therapy demonstrated significant improvements in sleep onset latency for shift workers.
• Melatonin administration effectively enhanced sleep efficiency in shift workers with sleep difficulties.
• The findings support melatonin as a viable option for managing sleep disturbances in shift workers.